More complete genetic map of scleroderma disease makes more effective medications possible

Scleroderma is an autoimmune disease that affects one out of every 10,000 people in Europe and North America, mostly middle-aged women, and causes death in a high percentage of cases. Scientists have now carried out the largest study to date of the disease with a sample of more than 5000 affected patients.